News

9.9%; p =0.002; Figure 2). Note that patients randomized to combination therapy who were titrated to losartan 100 mg/HCTZ 25 mg at Week 2 for safety reasons were not considered to have achieved ...
Hydrochlorothiazide should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C), for shorter periods of time ...
The highest dose of Val/HCTZ combination (320/25 mg), component monotherapies (Val 320 mg, HCTZ 25 mg) and placebo were selected for this analysis (N=675, 52.1% men, 68.6% Caucasians ...
Typical dosage: 25 to 100 mg each day, taken by mouth as a single or divided dose. Intermittent therapy: Instead of having you take hydrochlorothiazide every day, your doctor might prescribe ...
The antihypertensive effect of hydrochlorothiazide (HCTZ) at the dose that is most often used--12.5 to 25 mg a day--is consistently inferior to that of most other antihypertensive drug classes ...
Medindia neither buys nor sells drugs. Hydrochlorothiazide (Hydrazide (25 mg)) is a thiazide diuretic, prescribed for high blood pressure (hypertension) and edema.It helps the kidneys to remove ...
The mean age was 72 years. At baseline, hydrochlorothiazide at a dose of 25 mg per day had been prescribed in 12,781 patients (94.5%). The mean baseline systolic blood pressure in each group was ...
The researchers randomly assigned 416 patients (median age, 49 years; 80% men) to either 12.5 mg (n = 105), 25 mg (n = 108) or 50mg (n = 101) of hydrochlorothiazide, or placebo (n = 102).
Nephrolithiasis is one of the most common conditions affecting the kidney and is characterized by a high risk of recurrence. Thiazide diuretic agents are widely used for prevention of the ...
Chlorthalidone appears to be more effective than hydrochlorothiazide in reducing ... follow-up was only 0.95 and 0.25 years. “As differences in outcomes for MACE in hypertension trials with ...
The rate of radiologic recurrence was significantly lower in the 25- and 50-mg hydrochlorothiazide groups compared with the placebo group: 32% and 34% vs 49%, respectively. At baseline ...